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Accepted 5 November 2011A 32-year-old, gravida 3, para 2, woman electively
underwent amniocentesis at 16 weeks of gestation. Cytoge-
netic analysis of cultured amniocytes revealed a karyotype of
47,XX,þ21[6]/46,XX[14]. In 20 colonies of cultured amnio-
cytes, six colonies had a karyotype of 47,XX,þ21, whereas the
other 14 colonies had a karyotype of 46,XX.Repeat amnio-
centesis was performed at 19 weeks of gestation. Interphase
fluorescence in situ hybridization (FISH) analysis on uncul-
tured amniocytes using the bacterial artificial chromosome
(BAC) clone probe RP11-91N21 (21q11.2) showed three 21q-
sepcific signals in 48.1% (25/52) of the amniocytes and two
21q-sepcific signals in 51.9% (27/52) of the amniocytes
(Fig. 1), indicating 48.1% mosaicism for trisomy 21 in
uncultured amniocytes. The cultured amniocytes had a karyo-
type of 47,XX,þ21[13]/46,XX[18] in the repeat amniocen-
tesis. The pregnancy was terminated at 21 weeks of gestation,
and a 420-g fetus was delivered with bilateral low-set ears.
Cytogenetic analyses revealed a karyotype of 47,XX,þ21[4]/
46,XX[36] in cord blood and a karyotype of 47,XX,þ21[20]/
46,XX[30] in umbilical cord. Quantitative fluorescent poly-
merase chain reaction (QF-PCR) analysis on the umbilical* Corresponding author. Department of Obstetrics and Gynecology, Mackay
Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan.
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http://dx.doi.org/10.1016/j.tjog.2012.07.035cord showed unequal fluorescent activity from two alleles with
a dosage ratio of 1:1.22 (Fig. 2).
A 40-year-old, gravida 3, para 1, woman underwent
amniocentesis at 17 weeks of gestation because of advanced
maternal age. Cytogenetic analysis of cultured amniocytes
revealed a karyotype of 47,XY,þ21[13]/46,XY[12].Repeat
amniocentesis was performed at 19 weeks of gestation.
Interphase FISH analysis on uncultured amniocytes using the
BAC clone probe RP11-91N21 (21q11.2) showed three 21q-
sepcific signals in 54% (27/50) of the amniocytes and two 21q-
sepcific signals in 46% (23/50) of the amniocytes, indicating
54% mosaicism for trisomy 21 in uncultured amniocytes. QF-
PCR analysis on uncultured amniocytes showed unequal
fluorescent activity from two alleles with a dosage ratio of 2:1
(Fig. 3). The cultured amniocytes had a karyotype of
47,XY,þ21[7]/46,XY[17] in the repeat amniocentesis. The
pregnancy was terminated at 22 weeks of gestation, and a 524-
g fetus was delivered with hypertelorism, a depressed nasal
bridge, low-set ears and malposition of the toes but without
dysplasia of mid phalanx of the fifth fingers (Fig. 4). Cyto-
genetic analyses revealed a karyotype of 47,XY,þ21[13]/
46,XY[27] in cord blood, a karyotype of 47,XY,þ21[5]/46,XY
[35] in umbilical cord and a karyotype of 47,XY,þ21 in
placenta (40/40 cells).
A 39-year-old, primigravid woman underwent amniocen-
tesis at 19 weeks of gestation because of advanced maternalcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Interphase fluorescence in situ hybridization analysis on uncultured amniocytes using a bacterial artificial chromosome probe RP11-91N21 (21q11.2;
spectrum green) shows (A) three green signals in an abnormal cell with trisomy 21; and (B) two green signals in a normal cell with disomy 21.
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a karyotype of 47,XY,þ21[5]/46,XY[14]. The parental
karyotypes were normal. Repeat amniocentesis was performed
at 22 weeks of gestation. Interphase FISH analysis on uncul-
tured amniocytes using the BAC clone probe RP11-91N21
(21q11.2) showed three 21q-sepcific signals in 23.1% (12/
52) of the amniocytes and two 21q-sepcific signals in 76.9%
(40/52) of the amniocytes, indicating 23.1% mosaicism for
trisomy 21 in uncultured amniocytes. QF-PCR analysis on
uncultured amniocytes showed unequal fluorescent activity
from two alleles with a paternal: maternal dosage ratio of 1:1.3
(Fig. 5). Oligonucleotide-based array comparative genomic
hybridization (aCGH) analysis on uncultured amniocytesD21S1446
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Fig. 2. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction (QF-PCR) assays at short tandem repeat (STR) markers
specific for chromosome 21 in the umbilical cord sample of Case 1. The
marker D21S1446 (21q22.3) shows two different alleles with unequal fluo-
rescent activity in umbilical cord.using CytoChip Oligo array (BlueGnome, Cambridge, UK)
showed a partial genomic gain in chromosome 21 (Fig. 6). The
molecular results were consistent with the diagnosis of mosaic
trisomy 21. The cultured amniocytes had a karyotype of
47,XY,þ21[4]/46,XY[17] in the repeat amniocentesis. The
parents elected to terminate the pregnancy at 24 weeks of
gestation, and a 704-g fetus was delivered without facial
dysmorphisms or dysplasia of mid phalanx of the fifth fingers
(Figs. 7 and 8). Cytogenetic analyses revealed a karyotype of
47,XY,þ21[2]/46,XY[8] in cord blood, 47,XY,þ21[1]/46,XY
[39] in umbilical cord.
We previously reported application of molecular cytoge-
netic techniques in uncultured amniocytes in prenatal diag-
nosis of mosaicism for trisomy 8, trisomy 9 and trisomy 2
[1e4]. In this report, we additionally provide evidence for
the usefulness of interphase FISH, QF-PCR and aCGH on
uncultured amniocytes in rapid positive confirmation ofD21S1435
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Fig. 3. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction (QF-PCR) assays at short tandem repeat (STR) markers of
D21S1435 (21q21.3) andD21S1446 (21q22.3) in the amniotic fluid samples with
uncultured amniocytes of Case 2. The markers D21S1435 and D21S1446 show
two different alleles with unequal fluorescent activity in uncultured amniocytes.
Fig. 4. The craniofacial appearance of the fetus in Case 2.
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repeat amniocentesis may be considered when there is insuf-
ficient number of cells or cultures to establish a diagnosis of
mosaicism, and the risk of abnormal outcome in pregnancies
with less than 50% cultured trisomic 21 cells and greater than
50% cultured trisomic 21 cells was 45% (27/60) versus 59.5%
(22/37). In this presentation, variation of the level of mosai-
cism between different cultured amniocytes was observed in
Cases 1 and 2. In Case 1, the first amniocentesis revealed 30%
cultured trisomic cells and the second amniocentesis revealed
42% cultured trisomic cells, and interphase FISH on uncul-
tured amniocytes revealed 48.1% trisomic cells. In Case 2, the
first amniocentesis revealed 52% cultured trisomic cells and
the second amniocentesis revealed 29.2% cultured trisomicD21S11
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Fig. 5. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction (QF-PCR) assays at short tandem repeat (STR) markers
of D21S11 (21q21.1) and D21S1436 (21q21.1) in the parents and uncultured
amniocytes of Case 3. The markers D21S11 and D21S1436 show two different
parental alleles with unequal fluorescent activity and a dosage increase in the
maternal allele in uncultured amniocytes.cells, and interphase FISH on uncultured amniocytes revealed
54% trisomic cells. In Case 3, the first amniocentesis revealed
26.3% cultured trisomic cells and the second amniocentesis
revealed 19% cultured trisomic cells, and interphase FISH on
uncultured amniocytes revealed 23.1% trisomic cells. In this
regard, interphase FISH analysis on uncultured amniocytes is
helpful for determining the probable level of mosaicism in
trisomy 21 mosaicism at amniocentesis.
In this study, QF-PCR was able to detect mosaicism for
trisomy 21 in uncultured amniocytes in Cases 2 and 3 with the
mosaic level of 54% (27/50) and 23.1% (12/52), respectively,
and aCGH using CytoChip Oligo array was able to detect
mosaicism for trisomy 21 in uncultured amniocytes in Case 3
with a mosaic level of 23.1%. QF-PCR assay has been re-
ported to detect mosaicism as low as 15% of the whole sample
[6], and aCGH has been reported to detect mosaicism as low
as 20% in the peripheral blood samples [7,8] or even the level
limit of 10% at prenatal diagnosis [9]. We previously
successfully detected mosaic trisomy by aCGH using Cyto-
Chip Oligo array in two independent cases on uncultured
amniocytes with 48% (12/25) mosaicism for trisomy 9 and
12% (6/50) mosaicism for trisomy 2, respectively [3,4].
However, the detection rate of mosaic trisomy using aCGH on
uncultured amniocytes is variable according to different
products of array chips. For instance, we previously failed to
detect mosaic trisomy by aCGH using CMDX array chips on
uncultured amniocytes in two separate cases with 25% (5/20)
mosaicism for trisomy 8 and 18% (9/50) mosaicism for
trisomy 9, respectively [1,2]. Lau et al [10] failed to detect
mosaic trisomy by QF-PCR on uncultured amniotic fluid
samples in two independent cases with 16.7% (5/30) and 2.9%
(1/35) mosaicism for trisomy 21, respectively. Therefore, QF-
PCR and aCGH may have difficulty in rapid positive confir-
mation of mosaic trisomy detected at amniocentesis in cases
with low-level mosaicism.
Wallerstein et al [5] suggested that fetal blood sampling has
a role in mosaic trisomy 21 as the risk for abnormal outcome
increases with positive confirmation with 1/4 (25%) positive
confirmation in phenotypically normal cases versus 3/6 (50%)
Fig. 6. Oligonucleotide-based array comparative genomic hybridization analysis using CytoChip Oligo array (BlueGnome, Cambridge, UK) on uncultured
amniocytes in Case 3 shows a partial genomic gain in chromosome 21.
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However, the percentage of trisomy 21 in lymphocytes is
usually lower than other tissues in individuals with mosaic
trisomy 21, and fetal blood sampling may lead to a false
negative result. For instance, in a study of 107 individuals with
mosaic trisomy 21, Papavassiliou et al [11] observed that
buccal cells showed a significantly higher frequency oftrisomy 21 than lymphocytes (48.06%  3.44% vs.
30.13%  3.99%; mean  standard error). In this study, the
percentage of trisomy 21 cells in uncultured amniocytes of
Cases 1e3 was 48.1%, 54% and 23.1%, respectively, and the
percentage of trisomy 21 cells in cord blood of Cases 1e3 was
10%, 32.5% and 20%, respectively. It is evident that uncul-
tured amniocytes have higher frequency of trisomy 21 cells
Fig. 7. The craniofacial appearance of the fetus in Case 3.
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accordingly interphase FISH on uncultured amniocytes will
provide more accurate information of the percentage of
trisomic cells than blood lymphocytes acquired by fetal blood
sampling.
It has been suggested that there is a significant positive
correlation between the percentage of mosaicism and the
severity of the phenotype, and an inverse correlation betweenFig. 8. The hand of Case 3 shows no dysplasia of midphalanx of the fifth
finger.overall survival and the percentage of mosaicism in patients
with mosaic trisomy 21 [11e13]. This presentation stresses
the importance of undertaking molecular cytogenetic analyses
on uncultured amniocytes in order to maximize the accuracy
of rapid positive confirmation of trisomy 21 mosaicism at
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